Legislation would set expiration for FDA’s accelerated approvals
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/PolicyRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy